Right heart catheterization in cardiogenic shock is associated with improved outcomes: insights from the nationwide readmissions database

S Ranka, I Mastoris, NK Kapur, RJ Tedford… - Journal of the …, 2021 - Am Heart Assoc
Background The usefulness of right heart catherization (RHC) has long been debated, and
thus, we aimed to study the real‐world impact of the use of RHC in cardiogenic shock. …

Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock

M Pahuja, S Ranka, O Chehab, T Mishra… - Catheterization and …, 2021 - Wiley Online Library
Background Bleeding complications and acute limb ischemia (ALI) are devastating vascular
complications in patients with ST‐segment elevation myocardial infarction (STEMI). …

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019

…, P Bhyan, PB Bhattad, F Aslam, S Ranka… - Annals of …, 2021 - Taylor & Francis
Hydroxychloroquine, initially used as an antimalarial, is used as an immunomodulatory and
anti-inflammatory agent for the management of autoimmune and rheumatic diseases such …

The 2017 European Society of Cardiology (ESC)/European Association of Cardiothoracic Surgeons (EACTS) Guidelines for Management of Valvular Heart Disease …

AK Martin, D Mohananey, S Ranka, H Riha… - … of cardiothoracic and …, 2018 - jcvaonline.com
EIGHT YEARS HAVE PASSED since the first joint effort in developing practice guidelines by
the European Society of Cardiology (ESC) and the European Association for Cardio-…

[HTML][HTML] Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis

T Dalia, S Lahan, S Ranka, A Goyal, S Zoubek… - Thrombosis journal, 2021 - Springer
Background Left ventricular thrombus (LVT) is not uncommon and pose a risk of systemic
embolism, which can be mitigated by adequate anticoagulation. Direct oral anticoagulants (…

[HTML][HTML] Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis

T Dalia, S Lahan, S Ranka, P Acharya, A Gautam… - Indian heart …, 2021 - Elsevier
Background Coronavirus disease 2019 (COVID-19) has been reported to cause worse
outcomes in patients with underlying cardiovascular disease, especially in patients with acute …

The effects of vitamin D supplementation and 25-hydroxyvitamin D levels on the risk of myocardial infarction and mortality

P Acharya, T Dalia, S Ranka, P Sethi… - Journal of the …, 2021 - academic.oup.com
Objective The aim of the study was to examine the effects of the vitamin D (Vit-D) treatment
and nontreatment on Vit-D–deficient patients without a prior history of myocardial infarction (…

Imaging of programmed cell death ligand 1: impact of protein concentration on distribution of anti-PD-L1 SPECT agents in an immunocompetent murine model of …

JR Nedrow, A Josefsson, S Park, S Ranka… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Programmed cell death ligand 1 (PD-L1) is part of an immune checkpoint system that is
essential for preventing autoimmunity and cancer. Recent approaches in immunotherapy that …

Association of Kidney Disease With Outcomes in COVID‐19: Results From the American Heart Association COVID‐19 Cardiovascular Disease Registry

A Rao, S Ranka, C Ayers, N Hendren… - Journal of the …, 2021 - Am Heart Assoc
Background Emerging evidence links acute kidney injury (AKI) in patients with COVID‐19
with higher mortality and respiratory morbidity, but the relationship of AKI with cardiovascular …

Machine-learning-based in-hospital mortality prediction for transcatheter mitral valve repair in the United States

DF Hernandez-Suarez, S Ranka, Y Kim, A Latib… - Cardiovascular …, 2021 - Elsevier
Background Transcatheter mitral valve repair (TMVR) utilization has increased significantly
in the United States over the last years. Yet, a risk-prediction tool for adverse events has not …